HAMP

Chr 19AR

hepcidin antimicrobial peptide

Also known as: HEPC, HFE2B, LEAP1, PLTR

The product encoded by this gene is involved in the maintenance of iron homeostasis, and it is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. The preproprotein is post-translationally cleaved into mature peptides of 20, 22 and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their beta-sheet structures. These peptides exhibit antimicrobial activity against bacteria and fungi. Mutations in this gene cause hemochromatosis type 2B, also known as juvenile hemochromatosis, a disease caused by severe iron overload that results in cardiomyopathy, cirrhosis, and endocrine failure. [provided by RefSeq, Oct 2014]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.811 OMIM phenotype
Clinical SummaryHAMP
🧬
Gene-Disease Validity (ClinGen)
hemochromatosis type 2B · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 21 VUS of 95 total submissions
💊
Clinical Trials
8 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — HAMP
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.81LOEUF
pLI 0.008
Z-score 0.20
OE 0.88 (0.391.81)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.15Z-score
OE missense 0.94 (0.731.21)
43 obs / 45.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.88 (0.391.81)
00.351.4
Missense OE?0.94 (0.731.21)
00.61.4
Synonymous OE?1.56
01.21.6
LoF obs/exp: 3 / 3.4Missense obs/exp: 43 / 45.9Syn Z: -1.90
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveHAMP-related haemochromatosis, juvenileLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.75top 25%
GOF
0.4085th %ile
LOF
0.3065th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

95 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic4
VUS21
Likely Benign50
Benign6
Conflicting6
4
Pathogenic
4
Likely Pathogenic
21
VUS
50
Likely Benign
6
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
1
0
0
4
Likely Pathogenic
1
2
1
0
4
VUS
2
17
2
0
21
Likely Benign
0
1
20
29
50
Benign
0
0
6
0
6
Conflicting
6
Total621292991

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap HAMP — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

HAMP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

ObesityObesity, Infant

Maternal Characteristics Associated With Child Growth and Adiposity

RECRUITING
NCT05798676Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. ViteriStarted 2019-05-02
overweight/obesity
Metabolic SyndromeDiabetesOxidative Stress

EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS

ENROLLING BY INVITATION
NCT07000825Phase NAUniversidade Federal da Fronteira SulStarted 2025-10-06
Intervention with yerba mate extract or placebo
Heart Failure

Metabolic Response to the Initiation of Heart Failure Therapy

RECRUITING
NCT06283420Vojtech Melenovsky, MD, PhDStarted 2024-08-23
Malnutrition PregnancyMalnutrition in ChildrenMalnutrition (Calorie)

Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

RECRUITING
NCT07195006University of ZimbabweStarted 2025-01-27
Malnutrition in pregnancy as exposurePoor WASH living conditions as exposure
Acute Coronary Syndromes (ACS)Iron DeficienciesElderly (People Aged 65 or More)

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

RECRUITING
NCT07476859Phase PHASE4Fundación para la Investigación del Hospital Clínico de ValenciaStarted 2026-03-05
Ferric Carboxymaltose Injection [Ferinject]
Micronutrient Status

Micronutrient Dose Response Study in Bangladesh

ACTIVE NOT RECRUITING
NCT06081114Phase NAJohns Hopkins Bloomberg School of Public HealthStarted 2023-10-22
Micronutrient Supplement
PregnancyIron Deficiency

Efficacy and Adverse Side Effects of Two Forms of Iron in Pregnancy

RECRUITING
NCT06014983Phase NAUniversity of British ColumbiaStarted 2024-04-12
Ferrous fumarateFerrous bisglycinate
Physiological AdaptationsSport PerformanceAerobic Capacity

Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies

NOT YET RECRUITING
NCT07130942Phase NAGdansk University of Physical Education and SportStarted 2025-10-01
Inhalation using a molecular hydrogen generator